Association of < em > PON1 < /em > , < em > APOE < /em > and < em > SDF-1 < /em > Gene Polymorphisms with Treatment Response to Intravitreal Anti-VEGF Treatment in Patients with Retinal Vein Occlusion

CONCLUSION: PON1 L55M SNP may serve as a promising genetic biomarker for predicting response to intravitreal anti-VEGF treatment in patients with macular oedema due to RVO.PMID:37997789 | DOI:10.1080/08820538.2023.2283028

Source: Seminars in Ophthalmology - November 24, 2023 Category: Opthalmology Authors: Antonios Ragkousis Dimitrios Kazantzis Ilias Georgalas Panagiotis Theodossiadis Christos Kroupis Irini Chatziralli Source Type: research